You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alemtuzumab

Showing 376 - 400 of 419
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukaemia, Patients Resistant to a Purine Analogous, Patients Relapsed With Purines Therapy Trial in Spain

Withdrawn
  • Chronic Lymphocytic Leukaemia
  • +2 more
  • Badalona, Barcelona, Spain
  • +31 more
Dec 28, 2011

Lymphoma, Leukemia Trial in Houston (Campath-1 H (Alemtuzumab), Fludarabine, Cyclophosphamide)

Completed
  • Lymphoma
  • Leukemia
  • Campath-1 H (Alemtuzumab)
  • +3 more
  • Houston, Texas
    U.T.M.D. Anderson Cancer Center
Oct 31, 2011

Peripheral T-cell Lymphoma Trial in Bangkok (CHOP regimen alternate with ESHAP regimen, Alemtuzumab)

Completed
  • Peripheral T-cell Lymphoma
  • CHOP regimen alternate with ESHAP regimen
  • Alemtuzumab
  • Bangkok, Thailand
    King Chulalongkorn Memorial Hospital
Oct 4, 2011

Lymphoma Trial in Houston (Cyclophosphamide, Fludarabine, Rituximab)

Completed
Has Results
  • Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 2, 2011

Lymphoma Trial in Houston (Campath-1H, G-CSF, GM-CSF)

Terminated
Has Results
  • Lymphoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Nov 8, 2011

Renal Transplant Trial in Madison (Campath-1H)

Completed
Has Results
  • Renal Transplant
  • Madison, Wisconsin
    University of Wisconsin
Sep 21, 2012

Vasculitis, Microscopic Polyangiitis, Granulomatosis With Polyangiitis Trial in Cambridge (Alemtuzumab)

Unknown status
  • Vasculitis
  • +3 more
  • Alemtuzumab
  • Cambridge, United Kingdom
    Addenbrooke's Hospital, University of Cambridge NHS Foundation T
Jul 28, 2011

Acute Rejection, Renal Transplantation Trial in Madison (Campath-1H, rituximab, myfortic)

Terminated
  • Acute Rejection
  • Renal Transplantation
  • Campath-1H, rituximab, myfortic
  • Madison, Wisconsin
    University of Wisconsin
Jun 22, 2012

End-Stage Renal Disease, Kidney Failure Trial in Moscow (biological, drug, procedure)

Unknown status
  • End-Stage Renal Disease
  • Kidney Failure
  • CD4+CD25+CD127lowFoxP3+ T regulatory cells injection
  • +7 more
  • Moscow, Russian Federation
  • +1 more
Nov 17, 2011

Organ Transplant Infection Prevention and Detection Project

Completed
  • Transplantation Infection
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Aug 14, 2012

    Kidney Transplantation Trial in United States (basiliximab, rabbit anti-thymocyte globulin, tacrolimus)

    Completed
    Has Results
    • Kidney Transplantation
    • Birmingham, Alabama
    • +28 more
    Aug 9, 2011

    Multiple Sclerosis Trial (Alemtuzumab)

    Unknown status
    • Multiple Sclerosis
    • Alemtuzumab
    • (no location specified)
    Apr 22, 2011

    Hematological Tumors, Hematopoietic Stem Cell Transplantation Trial in Oklahoma City (Busulfex, Fludarabine, ALemtuzumab)

    Completed
    Has Results
    • Hematological Neoplasms
    • Hematopoietic Stem Cell Transplantation
    • Busulfex, Fludarabine, ALemtuzumab
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Mar 23, 2011

    Type 1 Diabetes, End-stage Renal Disease Trial in Fuzhou (simultaneous islet-kidney transplantation)

    Completed
    • Type 1 Diabetes Mellitus
    • End-stage Renal Disease
    • simultaneous islet-kidney transplantation
    • Fuzhou, Fujian, China
      Fuzhou General Hospital
    Sep 15, 2011

    Bone Marrow Failure, Osteopetrosis, Fanconi Anemia Trial in New York (Fludarabine, Cyclophosphamide, Cyclophosphamide 40)

    Unknown status
    • Bone Marrow Failure
    • +3 more
    • New York, New York
      Columbia University Medical Center
    Oct 18, 2011

    Idiopathic Thrombocytopenic Purpura, Anemia, Hemolytic, Autoimmune Trial in Monterrey (Alemtuzumab, Rituximab)

    Completed
    • Idiopathic Thrombocytopenic Purpura
    • Anemia, Hemolytic, Autoimmune
    • Alemtuzumab, Rituximab
    • Monterrey, Nuevo Leon, Mexico
      Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
    Aug 27, 2010

    Chronic Lymphocytic Leukemia Trial in Netherlands (Dasatinib)

    Unknown status
    • Chronic Lymphocytic Leukemia
    • Maastricht, Limburg, Netherlands
    • +3 more
    Aug 29, 2011

    Transplantation, Liver Trial in Rochester (Campath-1H and Tacrolimus)

    Completed
    • Transplantation, Liver
    • Campath-1H and Tacrolimus
    • Rochester, Minnesota
      Mayo Clinic
    May 20, 2011

    Bronchiolitis Obliterans, Immunosuppression Trial in Worldwide (Tacrolimus, Cyclosporine)

    Completed
    • Bronchiolitis Obliterans
    • Immunosuppression
    • Sydney, Australia
    • +13 more
    Sep 6, 2011

    Myositis, Inclusion Body Trial run by the NINDS (Alemtuzumab (Campath))

    Completed
    • Myositis, Inclusion Body
    • Alemtuzumab (Campath)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 16, 2010

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Jerusalem (Campath-1H /ATG)

    Withdrawn
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Campath-1H /ATG
    • Jerusalem, Israel
      Hadassah Medical Organization
    Apr 7, 2011

    Autoimmune Hemolytic Disease (Cold Type) (Warm Type) Trial in MIlan, Milan (prednisone, low dose rituximab)

    Completed
    • Autoimmune Hemolytic Disease (Cold Type) (Warm Type)
    • prednisone, low dose rituximab
    • MIlan, Italy
    • +1 more
    Apr 29, 2011

    Chronic Myeloid Leukemia Trial in New York (Reduced Intensity Conditioning, Busulfan and Fludarabine)

    Terminated
    • Chronic Myeloid Leukemia
    • Reduced Intensity Conditioning, Busulfan and Fludarabine
    • New York, New York
      Morgan Stanley Children's Hospital of NYP
    Apr 12, 2011

    Non-Hodgkins Lymphoma Trial (Rituximab, Fludarabine, CAMPTH-1H)

    Completed
    • Non-Hodgkins Lymphoma
    • (no location specified)
    Dec 29, 2010

    Chronic Lymphocytic Leukaemia Trial (Alemtuzumab, Methyprednisolone)

    Completed
    • Chronic Lymphocytic Leukaemia
    • (no location specified)
    Dec 15, 2009